Evidence map›Paper›PMID 24935962›Full record

ArticleCirculation research2014

Embryonic stem cell-derived cardiac myocytes are not ready for human trials.

Mark E Anderson, Joshua Goldhaber, Steven R Houser, Michel Puceat, Mark A Sussman

Abstract readComment
In one paragraph

Article in Circulation research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Review
  3. Targeted delivery of engineered adipose-derived stem cell secretome to promote cardiac repair after myocardial infarction.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  4. Cardiac commitment driven by MyoD expression in pericardial stem cells.Frontiers in cell and developmental biology · 2024
    Article
  5. Harnessing developmental cues for cardiomyocyte production.Development (Cambridge, England) · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mark E AndersonFrom the Departments of Internal Medicine and Molecular Physiology & Biophysics, Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City (M.E.A); Cedars-Sinai Heart Institute, Los Angeles, CA (J.G.); Department of Physiology and Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA (S.R.H.); INSERM UMR 910, Génétique médicale et génomique fonctionnelle, Université Aix Marseille, Team Physiopathology of Cardiac Development, Faculté de Medecine La Timone, Marseille, France (M.P.); and Biology Department, Integrated Regenerative Research Institute, San Diego State University, CA (M.A.S.). heartman4ever@icloud.com.
Joshua GoldhaberFrom the Departments of Internal Medicine and Molecular Physiology & Biophysics, Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City (M.E.A); Cedars-Sinai Heart Institute, Los Angeles, CA (J.G.); Department of Physiology and Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA (S.R.H.); INSERM UMR 910, Génétique médicale et génomique fonctionnelle, Université Aix Marseille, Team Physiopathology of Cardiac Development, Faculté de Medecine La Timone, Marseille, France (M.P.); and Biology Department, Integrated Regenerative Research Institute, San Diego State University, CA (M.A.S.).
Steven R HouserFrom the Departments of Internal Medicine and Molecular Physiology & Biophysics, Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City (M.E.A); Cedars-Sinai Heart Institute, Los Angeles, CA (J.G.); Department of Physiology and Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA (S.R.H.); INSERM UMR 910, Génétique médicale et génomique fonctionnelle, Université Aix Marseille, Team Physiopathology of Cardiac Development, Faculté de Medecine La Timone, Marseille, France (M.P.); and Biology Department, Integrated Regenerative Research Institute, San Diego State University, CA (M.A.S.).
Michel PuceatFrom the Departments of Internal Medicine and Molecular Physiology & Biophysics, Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City (M.E.A); Cedars-Sinai Heart Institute, Los Angeles, CA (J.G.); Department of Physiology and Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA (S.R.H.); INSERM UMR 910, Génétique médicale et génomique fonctionnelle, Université Aix Marseille, Team Physiopathology of Cardiac Development, Faculté de Medecine La Timone, Marseille, France (M.P.); and Biology Department, Integrated Regenerative Research Institute, San Diego State University, CA (M.A.S.).
Mark A SussmanFrom the Departments of Internal Medicine and Molecular Physiology & Biophysics, Cardiovascular Research Center, Carver College of Medicine, University of Iowa, Iowa City (M.E.A); Cedars-Sinai Heart Institute, Los Angeles, CA (J.G.); Department of Physiology and Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA (S.R.H.); INSERM UMR 910, Génétique médicale et génomique fonctionnelle, Université Aix Marseille, Team Physiopathology of Cardiac Development, Faculté de Medecine La Timone, Marseille, France (M.P.); and Biology Department, Integrated Regenerative Research Institute, San Diego State University, CA (M.A.S.).

Funding

Surgery, Physiology and ImmunohistopathologyP01HL085577 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2006 to 2017
$18.4M
Regulation of Signal Transduction to Treat Heart FailureR01HL067245 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2001 to 2021
$6.0M
Molecular Biology of Cardiac Sodium-Calcium ExchangeR01HL048509 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GOLDHABER, JOSHUA I, PHILIPSON, KENNETH · 2002 to 2016
$4.7M
Metabolic Regulation of Cardiac E-C CouplingR01HL070828 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GOLDHABER, JOSHUA I · 2002 to 2013
$3.8M
Stem Cell Signaling in the Pathologically Challenged MyocardiumR37HL091102 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2008 to 2017
$3.8M
Beta-adrenergic signaling: double edged sword of myocardial repairR01HL117163 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2013 to 2017
$1.9M
Antagonism of myocardial aging and senescence with Pim-1 kinaseR01HL105759 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2011 to 2015
$1.8M
Enhanced Myocardial Repair with CardioClusters and CardioChimerasR01HL122525 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2014 to 2017
$1.5M
Cardioprotection by optimizing mTOR activityR01HL113647 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2013 to 2016
$1.5M
Molecular Engineering of Damaged Myocardium To Enhance Regeneration And RepairR01HL113656 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2012 to 2013
$667k
NHLBI NIH HHS P01 HL085577NHLBI NIH HHS R01 HL048509NHLBI NIH HHS R01 HL067245NHLBI NIH HHS R01HL067245NHLBI NIH HHS R01 HL070828NHLBI NIH HHS R01 HL105759NHLBI NIH HHS R01HL105759NHLBI NIH HHS R01 HL113647NHLBI NIH HHS R01 HL113656NHLBI NIH HHS R01 HL117163NHLBI NIH HHS R01 HL122525NHLBI NIH HHS R37 HL091102NHLBI NIH HHS R37HL091102
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HeartRegenerationAnimalsEmbryonic Stem CellsHumansMaleMyocardial InfarctionMyocytes, Cardiac

Identifiers

PMID24935962
PMCPMC4133694

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.